Oral Molnupiravir to Treat Mild-to-Moderate Covid-19 | NEJM

Effective antivirals are needed to address the Covid-19 pandemic. Molnupiravir, an oral, small-molecule antiviral prodrug, could ultimately render SARS-CoV-2 noninfectious and unable to replicate. New research findings are summarized in a short video.
To see the full article, follow this link: nej.md/3E2o9wP

[@annettehylton4881]

Was rx this on day 3 helped so much by the next day could finally swallow. Praise God🎉

[@samilucille1]

It works!!¡ I was prescribed this in early stages of Covid as I suffer from asthma ,Day 6 iso I'm also cleared up

[@fielddaysg07]

Prescribed this on Day 2.5, 5 days of medication later, completely recovered.
Thank you whoever discovered or invented this drug, absolute miracle